JRSIS have submitted prospectus to SEC


March 2014 | byEden Hall Global Capital Co., Ltd


JRSIS Health Care Corporation have submitted its much anticipated prospectus to the U.S. Securities and Exchange Commission (the “SEC”), seeking to raise $4,580,000 via the public offering of 8,000,000 shares.

For more detailed information about exact institutions, please refer to the following website:

SEC website:  http://www.sec.gov/Archives/edgar/data/1597892/000114420414013680/v370774_s1.htm

JRSIS investor website: www.jhcc.cn

As a holding company, JRSIS Health Care Corporation relies on Jiarun Hospital to conduct 100% of the businesses and operations. For the year end December 31, 2012, we have generated revenues of $3,481,100, with assets of $1,614,754 as of December 31, 2012, and we have generated net income of $1,145,094. For the year end of December 31, 2013, we have generated revenues of $4,351,236, with assets of $18,519,798, and we have gene rated net income of $1,322,692.

On a three years basis, JRSIS’s revenue has been growing at a compound rate of approximately 28.00% annually and the Hospital anticipates this trend will remains in the high double digits as long as JRSIS’s facility operates at current level of patient and services efficiency. However, accounting for the fact that the hospital is working close to its maximum capacity, this growth trend may only extend for only 2 years unless physical capacity of the hospital is increased. In consideration of this future growth cap, the management of JRSIS is building a new medical facility in the heart of Harbin city that will be 26storeys high and contain over 500 open beds and 10-15 operation rooms. The hospital completed construction in November 2013. It is now in the process of being decorated, having regard to both patient comfort and aesthetics and our responsibility to provide comfortable staff work environments. Action is also underway to review and purchase modern medical equipment to ensure that the hospital can provide a very high standard of patient care. This process is anticipated for completion in 2014 Q3, at which time the new hospital will become the largest medical facility (both private and public) in the municipality. 

With more than 30 years working and business experience in health and medical services industry, management believes that we have strong opportunities to acquire other similar and/or smaller size hospitals in second tier cities throughout C

IR Team: Eden Hall Global Capital Co., Ltd 


Tel: 86-135.1001.6379. 

Email: mary20116688@163.com 

Skype: marymary4098

WechatEdenhallcapital Edenhallcapital2

Address: Unit B&C 20/F Full Win Commercial Centre, 573 Nathan Road, Yaumatei, Kowloon, Hong Kong